Michael C. Donegan - 23 Mar 2022 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
CAO and VP of Finance
Signature
/s/ Michael D. Donegan
Issuer symbol
TXMD
Transactions as of
23 Mar 2022
Net transactions value
$0
Form type
4
Filing time
28 Mar 2022, 07:00:13 UTC
Previous filing
02 Dec 2021
Next filing
31 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Award $0 +120,000 $0.000000 120,000 23 Mar 2022 Common Stock 120,000 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.